Standards and Guidelines for Biopolymers in Tissue‐Engineered Medical Products ASTM Alginate and Chitosan Standard Guides

• Published in: Annals of the New York Academy of Sciences Vol. 944; no. 1; pp. 388 - 397
• Main Authors: DORNISH, MICHAEL, KAPLAN, DAVID, SKAUGRUD, ØYVIND
• Format: Journal Article
• Language: English
• Published: 01.01.2001
• ISSN: 0077-8923; 1749-6632
• DOI: 10.1111/j.1749-6632.2001.tb03850.x

A bstract : The American Society for Testing and Materials (ASTM) is making a concerted effort to establish standards and guidelines for the entire field of tissue‐engineered medical products (TEMPS). Safety, consistency, and functionality of biomaterials used as matrices, scaffolds, and immobilizing agents in TEMPS are a concern. Therefore, the ASTM has established a number of task groups to produce standards and guidelines for such biomaterials. Alginate is a naturally occurring biomaterial used for immobilizing living cells to form an artificial organ, such as encapsulated pancreatic islets. In order to aid in successful clinical applications and to help expedite regulatory approval, the alginate used must be fully documented. The ASTM alginate guide gives information on selection of testing methodologies and safety criteria. Critical parameters such as monomer content, molecular weight, and viscosity, in addition to more general parameters, such as dry matter content, heavy metal content, bioburden, and endotoxin content are described in the ASTM document. In a like manner, the characterization parameters for chitosan, a bioadhesive polycationic polysaccharide, are described in a separate guide. For chitosan, the degree of deacetylation is of critical importance. Control of protein content and, hence, potential for hypersensitivity, endotoxin content, and total bioburden are important in chitosan preparations for TEMPS. Together these two guides represent part of the effort on behalf of the ASTM and other interested parties to ensure quality and standardization in TEMPS.